How to Find Where Your Franchise Deals Are Dying
Candidates enter your pipeline. Some become franchisees. Most don't. Somewhere between entry and award, deals die.
Where? And why?
Finding where deals die reveals what to fix. Most franchisors don't look closely enough to see the patterns.
The Pipeline Autopsy
Deals die at identifiable stages. Stage-level conversion analysis reveals the mortality pattern.
| Stage | Entry Count | Exit Count | Conversion | Death Rate |
|---|---|---|---|---|
| Lead | 500 | 150 | 30% | 70% |
| Discovery | 150 | 75 | 50% | 50% |
| FDD | 75 | 30 | 40% | 60% |
| Validation | 30 | 18 | 60% | 40% |
| Discovery Day | 18 | 12 | 67% | 33% |
| Award | 12 | - | 2.4% overall | - |
Each stage has death rate. Some death is healthy - unqualified candidates should exit. But unusual death rates at specific stages signal problems to address.
Every stage is a diagnostic opportunity. Death patterns reveal system health.
Early Stage Death
High early-stage mortality often indicates lead quality problems.
| Early Death Pattern | Likely Cause |
|---|---|
| Most leads never respond | Lead quality issue |
| Leads respond but don't qualify | Source targeting problem |
| Leads qualify but don't engage | Value proposition unclear |
Early death is expected. But if it's excessive, you're investing in leads that were never convertible.
Mid-Stage Death
Mid-stage death - between FDD and validation - often indicates process problems.
| Mid-Stage Death Pattern | Likely Cause |
|---|---|
| Drop after FDD receipt | FDD concerns, investment shock |
| Drop during validation | Negative franchisee feedback |
| Drop before Discovery Day | Commitment wavering |
Mid-stage death is expensive. You've invested discovery calls, FDD preparation, and relationship building. The candidate invested time. Something broke the momentum.
Late-Stage Death
Late-stage death is most painful. The candidate completed validation, attended Discovery Day, seemed ready to proceed. Then... nothing.
| Late Death Pattern | Likely Cause |
|---|---|
| Post-Discovery Day silence | Something happened at DD |
| Endless delay after DD | Commitment or financing issues |
| Last-minute withdrawal | Fear, competing option, family pressure |
Late-stage death warrants individual analysis. Each late death has a story. Understanding those stories reveals patterns.
A deal that dies after Discovery Day should prompt a post-mortem. What happened?
The Diagnostic Questions
At each stage, ask diagnostic questions.
Lead Stage
| Question | What Answer Reveals |
|---|---|
| What percentage of leads respond to outreach? | Lead quality |
| What percentage meet basic qualification? | Source targeting |
| What percentage engage beyond first contact? | Value proposition clarity |
Discovery Stage
| Question | What Answer Reveals |
|---|---|
| What percentage advance to FDD? | Discovery effectiveness |
| What reasons do non-advancers give? | Objection patterns |
| How long does discovery take? | Process efficiency |
FDD Stage
| Question | What Answer Reveals |
|---|---|
| What percentage complete FDD review? | Document concerns |
| What questions arise most? | Information gaps |
| How long from FDD to validation? | Momentum maintenance |
Validation Stage
| Question | What Answer Reveals |
|---|---|
| What percentage complete validation? | Franchisee feedback quality |
| What concerns emerge from calls? | Network health issues |
| How long does validation take? | Process management |
Discovery Day Stage
| Question | What Answer Reveals |
|---|---|
| What percentage of DD attendees award? | DD effectiveness |
| What happens in the week after DD? | Follow-up quality |
| What reasons do non-awarders give? | Final barriers |
The Fix Prioritization
Not all death points deserve equal attention. Prioritize based on impact.
| Prioritization Factor | Consideration |
|---|---|
| Volume impact | Fixing high-volume death stages affects more deals |
| Resource investment | Later stages mean more invested per death |
| Fixability | Some problems are easier to solve |
| Root cause vs. symptom | Address causes, not just symptoms |
A 10% improvement in lead-to-discovery conversion affects 500 leads. A 10% improvement in validation-to-DD conversion affects 30 candidates. But those 30 have far more invested.
The Systematic Approach
Building diagnostic capability requires systematic approach.
| Capability | Purpose |
|---|---|
| Stage-level tracking | Know where candidates are |
| Exit reason capture | Understand why they leave |
| Regular analysis | Spot patterns over time |
| Intervention testing | Try improvements, measure results |
Without systematic tracking, you're guessing about where deals die.
The Action Loop
Diagnosis without action is academic. The value is in the loop.
| Loop Stage | Activity |
|---|---|
| Measure | Track stage conversion |
| Analyze | Identify death points |
| Hypothesize | Propose causes |
| Intervene | Implement changes |
| Remeasure | Evaluate impact |
| Iterate | Continuous improvement |
Find where deals die. Fix the problems. Measure the improvement. Repeat.
Ready to talk about what franchise development should look like for your brand? Start the conversation at unitlockfranchising.com/get-started.
Ready to scale your franchise?
Let's discuss how UnitLock can help you grow the right way.
Get Started